摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[N-tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide | 177198-29-7

中文名称
——
中文别名
——
英文名称
3-[N-tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide
英文别名
3-[N-Tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide;4-[(4S,5S)-5-[(2R)-3-(butylamino)-2-methyl-3-oxopropyl]-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-1,3-oxazolidin-4-yl]-3,3-dimethylbutanoic acid
3-[N-tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide化学式
CAS
177198-29-7
化学式
C24H44N2O6
mdl
——
分子量
456.623
InChiKey
ZQWAYWLCNSVJSF-SQNIBIBYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    32
  • 可旋转键数:
    12
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    105
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    (±)-N-(1,2,3,4-tetrahydroquinolin-3-yl)propionamide3-[N-tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide 生成 5(S)-Amino-4(S)-hydroxy-2(R),7,7-trimethyl-8-[3(R,S)-ethylcarbonylamino-1,2,3,4-tetrahydroquinolin-1-ylcarbonyl]-octanoic acid (N-butyl)amide
    参考文献:
    名称:
    2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide
    摘要:
    公式I的化合物##STR1##中,其中R.sub.1是芳基氨基,N-芳基-N-(较低烷氧基-较低烷基)-氨基,N-芳基-N-芳基-较低烷基-氨基或通过环碳原子连接的杂环基,X是羰基或亚甲基基团,R.sub.2和R.sub.3彼此独立地是氢或较低烷基,或者与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.4是氢,较低烷基,较低烷酰基或较低烷氧羰基,R.sub.5是羟基,较低烷酰氧基或较低烷氧羰氧基,R.sub.6是氢,较低烷基,较低烯基,较低炔基,环烷基,环烷基-较低烷基,芳基-较低烷基或杂环芳基-较低烷基,在杂环芳基环中有5到7个环原子,R.sub.7是氢或较低烷基,或者R.sub.6和R.sub.7与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.8表示脂肪,环脂肪-脂肪或杂环脂肪基团,它们的盐可用作治疗高血压药物的活性成分。
    公开号:
    US05719141A1
  • 作为产物:
    描述:
    3-[3-tert-butoxycarbonyl-4(S)-(4-hydroxy-2,2-dimethylbutyl)-2,2-dimethyloxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide 在 ruthenium trichloride hydrate sodium periodate 作用下, 以 四氯化碳乙醚乙腈 为溶剂, 生成 3-[N-tert-butoxycarbonyl-4(S)-(3-carboxy-2,2-dimethylpropyl)-2,2-dimethyl-1,3-oxazolidin-5(S)-yl]-2(R)-methyl-propionic acid (N-butyl)amide
    参考文献:
    名称:
    2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide
    摘要:
    公式I的化合物##STR1##中,其中R.sub.1是芳基氨基,N-芳基-N-(较低烷氧基-较低烷基)-氨基,N-芳基-N-芳基-较低烷基-氨基或通过环碳原子连接的杂环基,X是羰基或亚甲基基团,R.sub.2和R.sub.3彼此独立地是氢或较低烷基,或者与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.4是氢,较低烷基,较低烷酰基或较低烷氧羰基,R.sub.5是羟基,较低烷酰氧基或较低烷氧羰氧基,R.sub.6是氢,较低烷基,较低烯基,较低炔基,环烷基,环烷基-较低烷基,芳基-较低烷基或杂环芳基-较低烷基,在杂环芳基环中有5到7个环原子,R.sub.7是氢或较低烷基,或者R.sub.6和R.sub.7与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.8表示脂肪,环脂肪-脂肪或杂环脂肪基团,它们的盐可用作治疗高血压药物的活性成分。
    公开号:
    US05719141A1
点击查看最新优质反应信息

文献信息

  • 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide
    申请人:Novartis Corporation
    公开号:US05719141A1
    公开(公告)日:1998-02-17
    Compounds of the formula I ##STR1## in which R.sub.1 is arylamino, N-aryl-N-(lower alkoxy-lower alkyl)-amino, N-aryl-N-aryl-lower alkyl-amino or heterocyclyl bonded via a ring carbon atom, X is a carbonyl or methylene group, R.sub.2 and R.sub.3 independently of one another are hydrogen or lower alkyl or, together with the carbon atom with which they are bonded, are a cycloalkylidene radical, R.sub.4 is hydrogen, lower alkyl, lower alkanoyl or lower alkoxycarbonyl, R.sub.5 is hydroxyl, lower alkanoyloxy or lower alkoxycarbonyloxy, R.sub.6 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, cycloalkyl-lower alkyl, aryl-lower alkyl or heteroaryl-lower alkyl having 5 to 7 ring atoms in the heteroaryl ring and R.sub.7 is hydrogen or lower alkyl, or R.sub.6 and R.sub.7, together with the carbon atom with which they are bonded, are a cydoalkylidene radical and R.sub.8 denotes an aliphatic, cycloaliphatic-aliphatic or heteroarylaliphatic radical, and their salts can be used as active ingredients for medicaments for treatment of high blood pressure.
    公式I的化合物##STR1##中,其中R.sub.1是芳基氨基,N-芳基-N-(较低烷氧基-较低烷基)-氨基,N-芳基-N-芳基-较低烷基-氨基或通过环碳原子连接的杂环基,X是羰基或亚甲基基团,R.sub.2和R.sub.3彼此独立地是氢或较低烷基,或者与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.4是氢,较低烷基,较低烷酰基或较低烷氧羰基,R.sub.5是羟基,较低烷酰氧基或较低烷氧羰氧基,R.sub.6是氢,较低烷基,较低烯基,较低炔基,环烷基,环烷基-较低烷基,芳基-较低烷基或杂环芳基-较低烷基,在杂环芳基环中有5到7个环原子,R.sub.7是氢或较低烷基,或者R.sub.6和R.sub.7与它们连接的碳原子一起是环烷基亚甲基基团,R.sub.8表示脂肪,环脂肪-脂肪或杂环脂肪基团,它们的盐可用作治疗高血压药物的活性成分。
查看更多